Michael Mitchell
Profile
Michael Mitchell worked as the Head of Investor Relations at The Medicines Co. from 2002 to 2013.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Former positions of Michael Mitchell
| Companies | Position | End |
|---|---|---|
| THE MEDICINES COMPANY | Investor Relations Contact | - |
Training of Michael Mitchell
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Michael Mitchell
